Trials / Recruiting
RecruitingNCT07108855
Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection
Detection of Upper Gastrointestinal Tumour Depth and Demarcation by Quantified Fluorescence Molecular Endoscopy Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic submucosal dissection (ESD) is a relatively new technique to treat superficial cancers in the upper gastrointestinal (GI) tract. Previous studies reported high en bloc resection rates (95%-97%). However, R0 resection rates (84.5%) suggest that the tumour is not radically removed in all cases, resulting in a risk of tumour recurrence. One of the key challenges is the limited accuracy in determining the depth of cancer invasion. To reduce the risk of tumour recurrence, the endoscopist would greatly benefit from proper and complete visualization of the tumour margin and depth during ESD. Several studies have shown that near-infrared quantified fluorescence molecular endoscopy (qFME) could serve as a red flag detection method and might be a useful imaging tool for tumour demarcation in the upper GI tract. The aim of this study is to evaluate the feasibility of ICG-enhanced near-infrared qFME to determine tumour demarcation and tumour depth in upper GI tumours (e.g. superficial esophageal and/or gastric adenocarcinoma (T1)) during ESD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine Green (IC-Green) | Systemic administration of indocyanine green during the endoscopic procedure. |
| DIAGNOSTIC_TEST | Fluorescence guided identification using indocyanine green | Near-infrared quantified fluorescence molecular endoscopy (qFME) will be used during the endoscopic procedure. |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2027-06-01
- Completion
- 2027-08-01
- First posted
- 2025-08-07
- Last updated
- 2025-08-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT07108855. Inclusion in this directory is not an endorsement.